Skip to main content
. 2022 Jan 24;11:790912. doi: 10.3389/fonc.2021.790912

Figure 7.

Figure 7

The effect of FBXO22 on immunological status in pan-cancer. (A) Correlation between FBXO22 and 28 tumor-associated immune cells, as calculated using the ssGSEA algorithm. (B) Differences in the various steps of the cancer immune cycle between groups with high and low FBXO22 expression. ns, no significant difference; * p < 0.05; ** p < 0.01; *** p < 0.001; **** p < 0.0001.